< Back to companies
Theremia

Theremia

Paris, France

Theremia aims to revolutionize drug development by using advanced machine learning and causal algorithms to improve drug efficacy and minimize side effects for diverse patient populations. Their interdisciplinary team focuses on enhancing clinical trials, shortening development times, and optimizing treatment outcomes in precision medicine and pharmacology.

Share
Shareable draft
Get Involved in Theremia

Company Info

Founded
2023
Website
www.theremia.health/
Only accessible to MedStartr community members. Join now

What do you think of Theremia?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Your scores and comments are shown with your review on this company's profile.

Get Involved in Theremia
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free